Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
CANCER:
Tongue Carcinoma
Associations
(5)
News
Trials
C4 | Sensitive
D | Sensitive
C4 | Resistant
D | Resistant
Show legend
Group by Gene:
Include preclinical:
Drug categories
PARP Inhibitors
Kinase Inhibitors
EGFR
Tyrosine Kinase Inhibitors
Cancel
EGFR inhibitor
cetuximab
osimertinib
Multi-tyrosine kinase inhibitor
pazopanib
ATR inhibitor, PARP inhibitor
ABT-888 + M6620
FGFR2 P253R
C4
FGFR2 P253R
|
Tongue Carcinoma
|
cetuximab
C4
FGFR2 P253R
|
Tongue Carcinoma
|
pazopanib
CHEK2 mutation
C4
CHEK2 mutation
|
Tongue Carcinoma
|
ABT-888 + M6620
EGFR wild-type
C4
EGFR wild-type
|
Tongue Carcinoma
|
osimertinib
EGF expression
D
EGF expression
|
Tongue Carcinoma
|
cetuximab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
